Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nω-nitro-L-arginine methyl ester-treated rats

Hypertension Research

Volumn 29, Issue 5, 2006, Pages 369-374

  Kanematsu, Yasuhisa ^a   Tsuchiya, Koichiro ^b   Ohnishi, Hideki ^a   Motobayashi, Yuki ^a   Izawa, Yuki ^a   Ishihara, Manabu ^a   Ishizawa, Keisuke ^a   Abe, Shinji ^c   Kawazoe, Kazuyoshi ^c   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Electron paramagnetic resonance; Nitric oxide; Nitrosylhemoglobin; Olmesartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; HYDRALAZINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OLMESARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON SPIN RESONANCE; ENDOTHELIAL DYSFUNCTION; HEMODYNAMICS; HYPERTENSION; IMAGE SUBTRACTION; LONG TERM CARE; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING; SYSTEMIC CIRCULATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENDOTHELIUM, VASCULAR; HEART RATE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HYDRALAZINE; HYPERTENSION; IMIDAZOLES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES;

EID: 33745636311     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.369     Document Type: Article

References (37)

1. Kirima K, Tsuchiya K, Sei H, et al: Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO. Am J Physiol Heart Circ Physiol 2003; 285: H589-H596.
2. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
3. Van de Voorde J, Leusen I: Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats. Am J Physiol 1986; 250: H711-H717.
4. Gohlke P, Pees C, Unger T: AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31: 349-355.
5. Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger T: Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin. J Cardiovasc Pharmacol 1994; 24: 462-469.
6. Yagi S, Morita T, Katayama S: Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress. Hypertens Res 2004; 27: 129-135.
7. Matsuda H, Hayashi K, Homma K, et al: Differing anti-proteinuric action of candesartan and losartan in chronic renal disease. Hypertens Res 2003; 26: 875-880.
8. Higashi Y, Chayama K, Yoshizumi M: Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress. Curr Med Chem Cardiovasc Hematol Agents 2005; 3: 133-148.
9. Okamoto M, Tsuchiya K, Kanematsu Y, et al: Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in kidney. Am J Physiol Renal Physiol 2005; 288: F182-F187.
10. Tsuchiya K, Kanematsu Y, Yoshizumi M, et al: Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol 2005; 288: H2163-H2170.
11. Katoh M, Egashira K, Usui M, et al: Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. Circ Res 1998; 83: 743-751.
12. Scrogin KE, Hatton DC, Chi Y, Luft FC: Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system. Am J Physiol 1998; 274: R367-R374.
13. Griendling KK, Alexander RW: Endothelial control of the cardiovascular system: recent advances. FASEB J 1996; 10: 283-292.
14. Amann K, Gassmann P, Buzello M, et al: Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats. Kidney Int 2000; 58: 153-161.
15. Higashi Y, Oshima T, Sasaki S, et al: Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension. Hypertension 1998; 32: 16-24.
16. Linz W, Jessen T, Becker RH, Scholkens BA, Wiemer G: Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 1997; 96: 3164-3172.
17. Mancini GB, Henry GC, Macaya C, et al: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 1996; 94: 258-265.
18. Koobi P, Kalliovalkama J, Jolma P, et al: AT1 receptor blockade improves vasorelaxation in experimental renal failure. Hypertension 2003; 41: 1364-1371.
19. Yavuz D, Koc M, Toprak A, et al: Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients. J Renin Angiotensin Aldosterone Syst 2003; 4: 197-203.
20. Koh KK, Ahn JY, Han SH, et al: Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Coll Cardiol 2003; 42: 905-910.
21. Pawloski JR, Hess DT, Stamler JS: Export by red blood cells of nitric oxide bioactivity. Nature 2001; 409: 622-626.
22. Kharitonov VG, Bonaventura J, Sharma VS: Interaction of nitric oxide with heme proteins using UV-VIS spectroscopy, in Feelisch M, Stamler S (eds): Method in Nitric Oxide Research. Chichester, John Wiley & Sons, 1996, pp 455-478.
23. Kumura E, Yoshimine T, Tanaka S, Hayakawa T, Shiga T, Kosaka H: Nitrosyl hemoglobin production during reperfusion after focal cerebral ischemia in rats. Neurosci Lett 1994; 177: 165-167.
24. Baker JE, Felix CC, Olinger GN, Kalyanaraman B: Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci U S A 1988; 85: 2786-2789.
25. Bazzani C, Bini A, Cainazzo MM, et al: High blood levels of nitric oxide in rats subjected to prolonged respiratory arrest and their modulation during adrenocorticotropin-induced resuscitation. Naunyn Schmiedebergs Arch Pharmacol 1999; 359:53-59.
26. Cantilena LR Jr, Smith RP, Frasur S, Kruszyna H, Kruszyna R, Wilcox DE: Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy. J Lab Clin Med 1992;120: 902-907.
27. Glover RE, Germolec DR, Patterson R, Walker NJ, Lucier GW, Mason RP: Endotoxin (lipopolysaccharide)-induced nitric oxide production in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated Fischer rats: detection of nitrosyl hemoproteins by EPR spectroscopy. Chem Res Toxicol 2000; 13: 1051-1055.
28. Hall DM, Buettner GR: In vivo spin trapping of nitric oxide by heme: electron paramagnetic resonance detection ex vivo. Methods Enzymol 1996; 268: 188-192.
29. Nakazawa H, Ichimori K, Shinozaki Y, Okino H, Hori S: Is superoxide demonstration by electron-spin resonance spectroscopy really superoxide? Am J Physiol 1988; 255: H213-H215.
30. Hatta T, Nakata T, Harada S, et al: Lowering of blood pressure improves endothelial dysfunction by increase of nitric oxide production in hypertensive rats. Hypertens Res 2002; 25: 455-460.
31. Takemoto M, Egashira K, Usui M, et al: Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 1997; 99: 278-287.
32. Takemoto M, Egashira K, Tomita H, et al: Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 1997; 30: 1621-1627.
33. Searles CD, Harrison DG: The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice. J Clin Invest 1999; 104: 1013-1014.
34. De Gennaro Colonna V, Rigamonti A, Fioretti S, et al: Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 2005; 516: 253-259.
35. Sosa-Canache B, Cierco M, Gutierrez CI, Israel A: Role of bradykinins and nitric oxide in the AT2 receptor-mediated hypotension. J Hum Hypertens 2000; 14 (Suppl 1): S40-S46.
36. Fukada SY, Tirapelli CR, de Godoy MA, de Oliveira AM: Mechanisms underlying the endothelium-independent relaxation induced by angiotensin II in rat aorta. J Cardiovasc Pharmacol 2005; 45: 136-143.
37. Cosentino F, Savoia C, De Paolis P, et al: Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens 2005; 18: 493-499.